Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Bree

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Urologic Oncology|November 20, 2022
Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorshipPatrick J Hensley, Zhigang Duan, Kelly Bree, et al.
World Journal of Urology|November 9, 2019
Robotic partial nephrectomy for clinical T2a renal mass is associated with improved trifecta outcome compared to open partial nephrectomy: a single surgeon comparative analysisFady Ghali, Amr A Elbakry, Zachary A Hamilton, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 19, 2026
Metastasis-directed radiotherapy for oligometastatic urothelial carcinoma of the bladder and upper tractPatrick Carriere, Omar Alhalabi, Jianjun Gao, et al.
Clinical and Translational Radiation Oncology|October 15, 2024
Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancerPatrick Carriere, Omar Alhalabi, Jianjun Gao, et al.
Cancer Discovery|May 13, 2026
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune ArchitectureKai Yu, Jianfeng Chen, Yu-Yi Chu, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Urologic Oncology|November 20, 2022
Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorshipPatrick J Hensley, Zhigang Duan, Kelly Bree, et al.
World Journal of Urology|November 9, 2019
Robotic partial nephrectomy for clinical T2a renal mass is associated with improved trifecta outcome compared to open partial nephrectomy: a single surgeon comparative analysisFady Ghali, Amr A Elbakry, Zachary A Hamilton, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 19, 2026
Metastasis-directed radiotherapy for oligometastatic urothelial carcinoma of the bladder and upper tractPatrick Carriere, Omar Alhalabi, Jianjun Gao, et al.
Clinical and Translational Radiation Oncology|October 15, 2024
Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancerPatrick Carriere, Omar Alhalabi, Jianjun Gao, et al.
Cancer Discovery|May 13, 2026
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune ArchitectureKai Yu, Jianfeng Chen, Yu-Yi Chu, et al.
Pageof 2